-
HUMAN, AI, OR BOTH? EVALUATING THE PERFORMANCE OF AI-ASSISTED ABSTRACT SCREENING IN SYSTEMATIC LITERATURE REVIEWS
Aug 11, 2026, 17:15 PM -
REAL-WORLD ECONOMIC IMPACTS OF ACUTE LYMPHOBLASTIC LEUKEMIA AND THEIR COST DRIVERS: INSIGHTS FROM STRUCTURAL EQUATION MODELING
Aug 11, 2026, 17:15 PM -
ANTIBIOTIC USAGE PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE TEACHING HOSPITAL
Aug 11, 2026, 17:15 PM -
SWITCHING OCRELIZUMAB FROM INTRAVENOUS TO SUBCUTANEOUS ADMINISTRATION: MODELING RELEASED NURSING AND CHAIR TIME IN A FRENCH DAY HOSPITAL
Aug 11, 2026, 17:15 PM -
PATIENT-REPORTED OUTCOMES AND ECONOMIC BURDEN BY ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK IN JAPAN: ANALYSIS FROM THE JAPAN NATIONAL HEALTH AND WELLNESS SURVEY
Aug 11, 2026, 17:15 PM -
EVALUATING NON-OS ENDPOINTS IN CHRONIC LYMPHOCYTIC LEUKEMIA TRIALS FOR HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:15 PM -
THE SCENARIO ANALYSES YOU FORGOT ARE THE ONES THE EAG RUNS: AN LLM SCENARIO-GENERATION AGENT BENCHMARKED AGAINST OMITTED AND EAG-IMPOSED SCENARIOS IN NICE ONCOLOGY APPRAISALS
Aug 11, 2026, 17:15 PM -
ENSURING CONTINUITY OF ACCESS TO HIGH-COST INNOVATIVE THERAPIES DURING QATAR'S MANDATORY HEALTH INSURANCE TRANSITION: EXPERT STAKEHOLDER PERSPECTIVES
Aug 11, 2026, 17:15 PM -
COMBINED DISCRETE CHOICE AND TIME TRADE-OFF METHODS TO ESTIMATE UTILITIES FOR THE SINO-NASAL OUTCOME TEST (SNOT-22) IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Aug 11, 2026, 17:15 PM -
PREVALENCE OF PAIN INTENSITY AND ITS ASSOCIATION WITH HEALTHCARE SERVICE UTILIZATION AMONG US ADULTS WITH PAIN
Aug 11, 2026, 17:15 PM -
BRIDGING THE GAP: ASSESSING THE PREDICTIVE ACCURACY OF EXPERT ELICITATION FOR LONG-TERM SURVIVAL OUTCOMES IN HAEMATO-ONCOLOGY
Aug 11, 2026, 17:15 PM -
ONE POLICY, MANY RESPONSES: MAPPING EUROPEAN STRATEGIES TO U.S. MOST-FAVOURED-NATION PRICING
Aug 11, 2026, 17:15 PM -
OUT-OF-POCKET COSTS AND FINANCIAL BURDEN OF DUCHENNE MUSCULAR DYSTROPHY IN GREECE: A CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:15 PM -
ECONOMIC BREAK-EVEN OF CAPACITY-RESERVATION MODELS FOR ANTIVIRAL PANDEMIC PREPAREDNESS IN GERMANY
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS ANALYSIS OF VORASIDENIB FOR IDH1- OR IDH2-MUTANT GRADE 2 GLIOMA IN TAIWAN
Aug 11, 2026, 17:15 PM -
HEARD BUT NOT SEEN: PATIENT AND CLINICIAN INPUT IN THE FIRST ORPHAN JCA
Aug 11, 2026, 17:15 PM -
IMPACT OF UPDATED REAL-WORLD VACCINE EFFECTIVENESS EVIDENCE ON THE ESTIMATED PUBLIC HEALTH AND ECONOMIC VALUE OF MRNA-1283 VERSUS BNT162B2 IN THE NETHERLANDS
Aug 11, 2026, 17:15 PM -
IDENTIFYING RESOURCE-USE AND IMPLEMENTATION PARAMETERS FOR ECONOMIC EVALUATION OF DIGITAL NONPHARMACOLOGIC INSOMNIA INTERVENTIONS IN OLDER ADULTS
Aug 11, 2026, 17:15 PM -
RECURRENT HEART FAILURE HOSPITALIZATIONS IN FRANCE: BURDEN AND PREDICTORS FROM A NATIONWIDE COHORT STUDY (PATHOS STUDY)
Aug 11, 2026, 17:15 PM -
REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE COSTS OF RHEUMATOID ARTHRITIS IN DUBAI: A CLAIMS-BASED ANALYSIS
Aug 11, 2026, 17:15 PM
